UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

Annals of oncology, 2003-09, Vol.14 (9), p.1430-1437

2003

Volltextzugriff (PDF)

Nomogram predicting individual survival following recurrence in advanced stage high-grade ovarian cancer from NRG Oncology/Gynecologic Oncology Group randomized trials of platinum and paclitaxel

Gynecologic oncology, 2017-06, Vol.145, p.61-61

2017

Volltextzugriff (PDF)

Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle

Journal of clinical oncology, 2005-09, Vol.23 (25), p.6107-6116

2005

Volltextzugriff (PDF)

A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus

Gynecologic oncology, 2024-11, Vol.190, p.209-214

2024

Volltextzugriff (PDF)

Effectiveness of pegylated liposomal doxorubicin maintenance therapy for platinum-sensitive recurrent epithelial ovarian cancer

Gynecologic oncology, 2018-06, Vol.149, p.49-49

2018

Volltextzugriff (PDF)

A phase II feasibility study of nab-paclitaxel and carboplatin in chemotherapy naïve epithelial neoplasms of the uterus

Gynecologic oncology, 2019-06, Vol.154, p.247-248

2019

Volltextzugriff (PDF)

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups

Annals of oncology, 2013-11, Vol.24 Suppl 8, p.viii63-viii68

2013

Volltextzugriff (PDF)

Camptothecins: a review of their development and schedules of administration

European journal of cancer (1990), 1998-09, Vol.34 (10), p.1500-1508

1998

Volltextzugriff (PDF)

Platinums: Extending Their Therapeutic Spectrum

Journal of chemotherapy (Florence), 2004-11, Vol.16 (sup4), p.77-82

2004

Volltextzugriff (PDF)

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

Breast diseases, 2005-07, Vol.16 (2), p.186-187

Muggia, F.M.

2005

Volltextzugriff (PDF)

A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas

Annals of oncology, 1998-10, Vol.9 (10), p.1131-1133

1998

Volltextzugriff (PDF)

Brain Metastases from Choriocarcinoma: Two Patients Illustrating Key Management Issues

Journal of chemotherapy (Florence), 2008-06, Vol.20 (3), p.405-407

2008

Volltextzugriff (PDF)

Clinical course of locally advanced breast cancer (LABC) patients with pathological response to primary concurrent 5-fluorouracil and radiation (FU/RT)

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.195-196

2001

Volltextzugriff (PDF)

'Retarded pharmaceuticals' assuming a clinical role

Onkologie, 2004-01, Vol.27 (5), p.437-438

Muggia, F M

2004

Volltextzugriff (PDF)

Seminoma and sarcoidosis: A cause for false positive mediastinal uptake in PET?

Annals of oncology, 1998-08, Vol.9 (8), p.924-924

1998

Volltextzugriff (PDF)

Protracted drug infusions in cancer treatment: An appraisal of 5-fluorouracil, doxorubicin, and platinums

Annals of oncology, 1993-11, Vol.4 (9), p.723-733

1993

Volltextzugriff (PDF)

Concurrent paclitaxel and radiation in locally advanced Breast Cancer

European journal of cancer (1990), 1998-09, Vol.34, p.S12-S12

1998

Volltextzugriff (PDF)

Randomized trial: Another opinion

Annals of oncology, 1992-06, Vol.3 (6), p.492-492

Muggia, F M

1992

Volltextzugriff (PDF)

Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts

Annals of oncology, 1991-02, Vol.2 (2), p.115-121

1991

Volltextzugriff (PDF)

Adjuvant therapy of colon cancer: lessons while looking for breakthroughs

Annals of oncology, 1991-10, Vol.2 (9), p.641-644

1991

Volltextzugriff (PDF)

Original article: Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): Tolerance and relation to leukocyte and buccal cell platinum-DNA adducts

Annals of oncology, 1991-02, Vol.2 (2), p.115-121

1991

Volltextzugriff (PDF)

Intraperitoneal therapy for ovarian cancer : analysis of fluid distribution by computerized tomography

Annals of oncology, 1992-02, Vol.3 (2), p.149-154

1992

Volltextzugriff (PDF)

Hypersensitivity to taxol and doxil: Experimental and clinical evidence for a causal role of complement activation

Immunopharmacology, 2000-08, Vol.49 (1-2), p.71-71

2000

Volltextzugriff (PDF)

Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: Analysis of results by prior sensitivity to platinum-based regimens

International journal of gynecology and obstetrics, 1994-06, Vol.45 (3), p.312-312

1994

Volltextzugriff (PDF)

A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer

Cancer treatment reviews, 1990-09, Vol.17 (2), p.161-163

1990

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(24)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Oncology
(22)
Female
(11)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Adult
(8)
Middle Aged
(8)
Pharmacology. Drug Treatments
(8)
Neoplasms - Drug Therapy
(7)
Aged
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Male
(6)
Chemotherapy
(5)
Doxorubicin - Administration & Dosage
(5)
Animals
(4)
Antineoplastic Agents
(4)
Cisplatin
(4)
Cisplatin - Administration & Dosage
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions

Nomogram predicting individual survival following recurrence in advanced stage high-grade ovarian cancer from NRG Oncology/Gynecologic Oncology Group randomized trials of platinum and paclitaxel

Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle

A phase 2 feasibility study of nab-paclitaxel and carboplatin in epithelial carcinoma of the uterus

Effectiveness of pegylated liposomal doxorubicin maintenance therapy for platinum-sensitive recurrent epithelial ovarian cancer

A phase II feasibility study of nab-paclitaxel and carboplatin in chemotherapy naïve epithelial neoplasms of the uterus

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups

Camptothecins: a review of their development and schedules of administration

Platinums: Extending Their Therapeutic Spectrum

Randomized Phase III Trial of Pegylated Liposomal Doxorubicin Versus Vinorelbine or Mitomycin C Plus Vinblastine in Women With Taxane-Refractory Advanced Breast Cancer

A phase II study of Doxil (liposomal doxorubicin): Lack of activity in poor prognosis soft tissue sarcomas

Brain Metastases from Choriocarcinoma: Two Patients Illustrating Key Management Issues

Clinical course of locally advanced breast cancer (LABC) patients with pathological response to primary concurrent 5-fluorouracil and radiation (FU/RT)

'Retarded pharmaceuticals' assuming a clinical role

Seminoma and sarcoidosis: A cause for false positive mediastinal uptake in PET?

Protracted drug infusions in cancer treatment: An appraisal of 5-fluorouracil, doxorubicin, and platinums

Concurrent paclitaxel and radiation in locally advanced Breast Cancer

Randomized trial: Another opinion

Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts

Adjuvant therapy of colon cancer: lessons while looking for breakthroughs

Original article: Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): Tolerance and relation to leukocyte and buccal cell platinum-DNA adducts

Intraperitoneal therapy for ovarian cancer : analysis of fluid distribution by computerized tomography

Hypersensitivity to taxol and doxil: Experimental and clinical evidence for a causal role of complement activation

Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: Analysis of results by prior sensitivity to platinum-based regimens

A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer

Suchergebnisse filtern